85 related articles for article (PubMed ID: 38347522)
1. Mediastinal Low-Grade Fibromyxoid Sarcoma With FUS-CREB3L2 Gene Fusion.
Williams CM; Du W; Mangano WE; Mei L
Cureus; 2021 Jun; 13(6):e15606. PubMed ID: 34277226
[TBL] [Abstract][Full Text] [Related]
2. A Rare Coexistence of Hybrid Tumor Low-grade Fibromyxoid Sarcoma/Sclerosing Epithelioid Fibrosarcoma and Hibernoma in the Same Thigh: A Case Report.
Alkameshki M; Nail LL; Tallegas M; Miquelestorena-Standley E; Samargandi R
J Orthop Case Rep; 2024 Mar; 14(3):130-135. PubMed ID: 38560304
[TBL] [Abstract][Full Text] [Related]
3. Sclerosing epithelioid fibrosarcoma of the jaw: a case report and literature review.
Amer S; Lazim A; Berstecher RW; Kuklani R
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Mar; ():. PubMed ID: 38553308
[TBL] [Abstract][Full Text] [Related]
4. Sclerosing Epithelioid Fibrosarcoma.
Warmke LM; Yu W; Meis JM
Surg Pathol Clin; 2024 Mar; 17(1):119-139. PubMed ID: 38278601
[TBL] [Abstract][Full Text] [Related]
5. Sclerosing epithelioid fibrosarcoma: in-depth review of a genetically heterogeneous tumor.
Murshed KA; Al-Bozom I; Ammar A
APMIS; 2021 Aug; 129(8):455-460. PubMed ID: 34048081
[TBL] [Abstract][Full Text] [Related]
6. Novel KMT2B gene mutation in MUC4 positive low-grade fibromyxoid sarcoma.
Zhang L; Luo L; Liu C; Li Z
Diagn Pathol; 2024 Feb; 19(1):30. PubMed ID: 38347522
[TBL] [Abstract][Full Text] [Related]
7. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
8. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features.
Mohamed M; Fisher C; Thway K
Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941
[TBL] [Abstract][Full Text] [Related]
9. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
[TBL] [Abstract][Full Text] [Related]
10. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.
Prieto-Granada C; Zhang L; Chen HW; Sung YS; Agaram NP; Jungbluth AA; Antonescu CR
Genes Chromosomes Cancer; 2015 Jan; 54(1):28-38. PubMed ID: 25231134
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
[TBL] [Abstract][Full Text] [Related]
12. Structure, Activity and Function of the MLL2 (KMT2B) Protein Lysine Methyltransferase.
Klonou A; Chlamydas S; Piperi C
Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440566
[TBL] [Abstract][Full Text] [Related]
13. Genomic alterations in KMT2 family predict outcome of immune checkpoint therapy in multiple cancers.
Zhang P; Huang Y
J Hematol Oncol; 2021 Mar; 14(1):39. PubMed ID: 33653367
[TBL] [Abstract][Full Text] [Related]
14. Low-grade fibromyxoid sarcoma incidentally discovered as an asymptomatic mediastinal mass: a case report and review of the literature.
Sajid MI; Arshad S; Abdul-Ghafar J; Fatimi SH; Din NU
J Med Case Rep; 2021 Feb; 15(1):50. PubMed ID: 33526082
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
